Lifecore Biomedical (LNDC) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 13 253 sessions, November 12, 2021 to November 14, 2022
- Largest daily move
- +13% close of December 14, 2021
- 1-year change
- -7.9% closing prices, November 12, 2021 to November 14, 2022
- 1-month change
- +7.1% closing prices, October 14, 2022 to November 14, 2022
Company Description
Lifecore Biomedical (Nasdaq: LNDC) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector.
LNDC declined 7.9% in the 12 months to November 14, 2022. The last closing price was $8.76.
This page collects what Stock Titan holds for LNDC, including price data and latest news.
Stock Performance
Lifecore Biomedical (LNDC) closed at $8.76 on November 14, 2022. In the 12 months to November 14, 2022, the price lost 7.9%.
LNDC Metrics & Rankings
Price returns through November 14, 2022. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Lifecore Biomedical has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include partnership, conferences, earnings. View all LNDC news →
SEC Filings
LNDC Company Profile & Sector Positioning
Lifecore Biomedical (LNDC) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing LNDC often look at related companies in the same sector, including Takeda Pharmaceutical Company Limited (TAK), Teva Pharmaceutical Industries Limited (TEVA), Haleon plc (HLN), Zoetis Inc. (ZTS), and United Therapeutics Corp (UTHR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LNDC's relative position within its industry.